Interleukin-8 receptor antagonists in pulmonary diseases

Current Opinion in Pharmacology

Volumn 1, Issue 3, 2001, Pages 242-247

  Hay, Douglas W P ^a   Sarau, Henry M ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Chemokines; Interleukin 8; Lung disease; Neutrophils; Therapy

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; INTERLEUKIN 8;

ANIMAL; DRUG ANTAGONISM; HUMAN; LUNG DISEASE; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; INTERLEUKIN-8; LUNG DISEASES; RECEPTORS, INTERLEUKIN-8A;

EID: 0035376543     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(01)00043-1     Document Type: Review

References (57)

1. Baggiolini M. Chemotactic and inflammatory cytokines-CXC and CC proteins. Adv Exp Med Biol. 351:1993;1-11.
2. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 55:1994;97-179.
3. Mukaida N., Harada A., Matsushima K. A novel leukocyte chemotactic and activating cytokine, interleukin-8 (IL-8). Cancer Treat Res. 80:1995;261-286.
4. Schroder J.M. Chemotactic cytokines in the epidermis. Ex Derm. 1:1992;12-19.
5. Murphy P.M. The molecular biology of leukocyte chemoattractant receptors. Ann Rev Immunol. 12:1994;593-633.
6. Holmes W.E., Lee J., Kuang W.J., Rice G.C., Wood W.I. Structure and functional expression of a human interleukin-8 receptor. Science. 253:1991;1278-1280.
7. Murphy P.M., Tiffany H.L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science. 253:1991;1280-1283.
8. Ahuja S.K., Murphy P.M. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRO beta, GRO gamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem. 271:1996;20545-20550.
9. Xu L., Kelvin D.J., Taub D.D., Ben-Baruch A., Oppenheim J.J., Wang J.M. Modulation of IL-8 receptor expression on purified human T lymphocyte is associated with changed chemotactic responses to IL-8. J Leuk Biol. 57:1995;335-344.
10. White J.R., Lee J.M., Young P.R., Hertzberg R.P., Jurewicz A.J., Chaikin M.A., Widdowson K., Foley J.J., Martin L.D., Griswold D.E., et al. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem. 273:1998;10095-10098.
11. Hashimoto S., Gon Y., Matsumoto K., Takeshita I., Horie T. N-acetylcysteine attenuates TNF-α-induced p38 MAP kinase activation and p38 MAP kinase-mediated IL-8 production by human pulmonary vascular endothelial cells. Br J Pharmacol. 132:2001;270-276.
12. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.-C., Yoshida M., Ding H.A., Gimbrone M.A., Luster A.D., Luscinskas F.W., Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature. 398:1999;718-723. This article is the first demonstration for a role of IL-8 in the firm adhesion of monocytes to endothelium, occurring under flow conditions.
13. Browning D.D., Diehl W.C., Hsu M.H., Schraufstatter I.U., Ye R.D. Autocrine regulation of interleukin-8 production in human monocytes. Am J Physiol Lung Cell Mol Physiol. 279:2000;L1129-L1136. This article describes the possible mechanisms whereby IL-8 is an autocrine regulator of IL-8 production, mediated by CXCR1 through activation of mitogen-activated protein kinase.
14. Bonecchi R., Facchetti F., Dusi S., Luini W., Lissandrini D., Simmelink M., Locati M., Bernasconi S., Allavena P., Brandt E., et al. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol. 164:2000;3862-3869. Describes how IL-8 and related chemokines can recruit mononuclear phagocytes in Th2-dominated responses.
15. Wuyts A., Schutyser E., Menten P., Struyf S., D'Haese A., Bult H., Opdenakker G., Proost P., Damme J.V. Biochemical and biological characterization of neutrophil chemotactic protein, a novel rabbit CXC hemokine from alveolar macrophages. Biochemistry. 39:2000;14549-14557.
16. Thompson B.P., Daughton D., Robbins G.A., Ghafouki M.A., Oehlerking M., Rennard S.I. Intramural airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis. 140:1989;1527-1537.
17. Jeffery P.K. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax. 53:1998;129-136.
18. Pesci A., Balbi B., Majori M., Corciani G., Bertacco S., Alciato P., Dormer C.F. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J. 12:1998;380-386.
19. Williams T.J., Jose P.J. Neutrophils in chronic obstructive pulmonary disease. Chronic Obstructive Pulmonary Disease: Pathogenesis to Treatment. 234:2001;136-148 Wiley, Chichester (Novartis Foundation Symposium). A recent review of the role of neutrophils iin the pathophysiology of COPD.
20. Gern J.E., Busse W.W. Association of rhinovirus infections and asthma. Clin Micro Rev. 12:1999;9-18.
21. Seemungal T.A., Harper-Owen R., Bhowmik A., Jeffries D.J., Wedzicha J.A. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Resp J. 16:2000;677-683.
22. Aaron S.D., Angel J.B., Lunau M., Wright K., Fex C., Le Saux N., Dales R.E. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 163:2001;349-355.
23. Wedzicha J.A. Mechanisms of exacerbations. Chronic Obstructive Pulmonary Disease: Pathogenesis to Treatment. 234:2001;84-93 Wiley, Chichester (Novartis Foundation Symposium).
24. + CXC chemokine-induced angiogenic activity. J Immunol. 165:2000;5269-5277. This paper describes how IL-8 and related chemokines, acting through CXCR2, mediate angiogensis without ongoing inflammation.
25. Nightingale J.A., Rogers D.F., Hart L.A., Kharitonov S.A., Chung K.F., Barnes P.J. Effect of inhaled endotoxin on induced sputum in normal, atopic, and asthmatic subjects. Thorax. 53:1998;563-571.
26. Yamamoto T., Kajikawa O., Martin T.R., Sharar S.R., Harlan J.M., Winn R.K. The role of leukocyte emigration and IL-8 on the development of lipopolysaccharide-induced lung injury in rabbits. J Immunol. 161:1998;5704-5709.
27. Broaddus V.C., Boylan A.M., Hoeffel J.M., Kim K.J., Sadick M., Chuntharapai A., Hebert C.A. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol. 152:1994;2960-2967.
28. Chignard M., Balloy V. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol. 279:2000;L1083-L1090.
29. Keane M.P., Belperio J.A., Moore T.A., Moore B.B., Arenberg D.A., Smith R.E., Burdick M.D., Kunkel S.L., Strieter R.M. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J Immunol. 162:1999;5511-5518. The authors demonstrate, in a murine bleomycin-induced lung injury model, that inhibition of angiogenesis is produced by an MIP-2 mAb without an effect on leucocyte recruitment.
30. Nakamura M., Fujishima S., Sawafuji M., Ishizaka A., Oguma T., Soejima K., Matsubara H., Tasaka S., Kikuchi K., Kobayashi K., et al. Importance of interleukin-8 in the development of reexpansion lung injury in rabbits. Am J Respir Crit Care Med. 161:2000;1030-1036.
31. Modelska K., Pittet J.F., Folkesson H.G., Broaddus V.C., Matthay M.A. Acid-induced lung injury protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits. Am J Respir Crit Care Med. 160:1999;1450-1456.
32. Laffon M., Pittet J.F., Modelska K., Matthay M.A., Young D.M. Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits. Am J Respir Crit Care Med. 160:1999;1443-1449. This paper reports that an IL-8 mAb could prevent both alveolar epithelial and lung endothelial barrier injury induced by smoke inhalation in rabbits.
33. Deng H., Mason N., Auten R.L. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med. 162:2000;2316-2323.
34. Martin T.R., Goodman R.B. The role of chemokines in the pathophysiology of the acute respiratory distress syndrome (ARDS). Herbert C.A. Chemokines in Disease: Biology and Clinical Research. 1999;81-110 Humana Press Inc, Totowa, NJ. A comprehensive review of the role of chemokines in ARDS.
35. Kurdowska A., Noble J.M., Steinberg K.P., Ruzinski J.T., Hudson L.D., Martin T.R. Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Am J Respir Crit Care Med. 163:2001;463-468.
36. Mazzarella G., Grella E., D'Auria D., Paciocco G. Phenotypic features of alveolar monocytes/macrophages and IL-8 gene activation by IL-1 and TNF-α in asthmatic patients. Allergy. 55:(suppl 61):2000;36-41.
37. Chen W., Hunninghake G.W. Effects of ragweed and Th-2 cytokines on the secretion of IL-8 in human airway epithelial cells. Exp Lung Res. 26:2000;229-239.
38. Lukacs N.W., Hogaboam C.M., Kunkel S.L., Chensue S.W., Burdick M.D., Evanoff H.L., Strieter R.M. Mast cells produce ENA-78, which can function as a potent neutrophil chemoattractant during allergic airway inflammation. J Leukoc Biol. 63:1998;746-751.
39. 2B receptor-mediated interleukin-8 production in human mast cells. Mol Pharmacol. 55:1999;726-735.
40. Mann-Jong Chang M., Juarez M., Hyde D.M., Wu R. Mechanism of dexamethasone-mediated interleukin-8 gene suppression in cultured airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 280:2001;L107-L115.
41. Lippert U., Artuc M., Grutzkau A., Moller A., Kenderessy-Szabo A., Schadendorf D., Norgauer J., Hartmann K., Schweitzer-Stenner R., Zuberbier T., et al. Expression and functional activity for the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol. 161:1998;2600-2608. Demonstrates the functional expression of both CXCR1 and CXCR2 on human mast cells, suggesting that IL-8 and related chemokines could be involved in their recruitment.
42. Petering H., Gotze O., Kimmig D., Smolarski R., Kapp A., Elsner J. The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. Blood. 93:1999;694-702.
43. Ulfman L.H., Joosten P.H., van der Linden J.A.M., Lammers J.W.J., Zwaginga J.J., Koenderman L. IL-8 induces a transient arrest of rolling eosinophils on human endothelial cells. J Immunol. 166:2001;588-595.
44. Biedermann T., Kneilling M., Mailhammer R., Maier K., Sander C.A., Kollias G., Kunkel S.L., Hultner L., Rocken M. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med. 192:2000;1441-1451.
45. + T cell activation. J Immunol. 166:2001;1233-1240.
46. Abdelilah S.G., Latifa K., Esra N., Cameron L., Bouchaib L., Nicolaides N.C., Levitt R.C., Hamid Q. Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: role in IL-8 release. J Immunol. 166:2001;2768-2774. Shows that the IL-9 receptor is upregulated on PMNs from asthmatics and that activation increase the production of IL-8. These data suggest a role for the IL-9 receptor in allergic diseases, mediated by IL-8.
47. Mitchell G.B., Khandaker M.H., Rahimpour R., Xu L., Lazarovits A.I., Pickering J.G., Suria H., Madrenas J., Pomerantz D.K., Feldman R.D., et al. CD45 modulation of CXCR1 and CXCR2 in human polymorphonuclear leukocytes. Eur J Immunol. 29:1999;1467-1476.
48. Abboud M.R., Taylor E.C., Habib D., Dantzler-Johnson T., Jackson S.M., Xu F., Laver J., Ballas S.K. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol. 111:2000;482-490.
49. Brennan S., Cooper D., Sly P.D. Directed neutrophil migration to IL-8 is increased in cystic fibrosis: a study of the effect of erythromycin. Thorax. 56:2001;62-64.
50. Papadaki H.A., Coulocheri S., Eliopoulos G.D.: Patients with chronic idiopathic neutropenia of adults have increased serum concentration of inflammatory cytokines and chemokines. Am J Hematol 65:271-277.
51. Fisher A.J., Donnelly S.C., Hirani N., Haslett C., Strieter R.M., Dark J.H., Corris P.A. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplatation. Am J Respir Crit Care Med. 163:2001;259-265.
52. Jones S.A., Dewald B., Clark-Lewis I., Baggiolini M. Chemokine antagonists that discriminate between interleukin-8 receptors. J Biol Chem. 272:1997;16166-16169.
53. McColl S.R., Clark-Lewis I. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. J Immunol. 163:1999;2829-2835.
54. Sarau H.M., Widdowson K.L., Palovich M.R., White J.R., Underwood D.C., Griswold D.E. Interleukin 8 receptor (CXCR2) antagonists, New Drugs Asthma. Allergy COPD. 31:2001;293-296. The description of the first small-molecule antagonist of CXCR2 that has in vivo activity in an animal model of inflammation.
55. Palovich M.R., Widdowson K., Elliott J.D., White J.R., Sarau H.M., Rutledge M.C., Bi J., Dede K.A., Benson G.M., Griswold D.E. et al.: Discovery and characterization of a novel series of potent CXCR2 antagonists with improved in vivo activity. Book of Abstracts 219th ACS National Meeting 2000 Medi-338.
56. Carson K., Roberta G., Ye Q., Luly J.R., Low J.E., Heilig D., Yang W., Qin S.: Pyrazines/quinoxalines as IL-8 receptor antagonists. Book of Abstracts 220th ACS National Meeting 2000 Medi-143.
57. Kemeny L., Szolnoky G., Kenderessy A.S., Gyulai R., Kiss M., Michel G., Nagy K., Ruzicka T., Dobozy A. Identification of a soluble interleukin-8 inhibitor in the supernatant of polymorphonuclear leukocytes. Immunol Letts. 64:1998;23-29.